Antiinflammatory Effects of the ETS Factor ERG in Endothelial Cells Are Mediated Through Transcriptional Repression of the Interleukin-8 Gene

ERG (Ets-related gene) is an ETS transcription factor that has recently been shown to regulate a number of endothelial cell (EC)-restricted genes including VE-cadherin, von Willebrand factor, endoglin, and intercellular adhesion molecule-2. Our preliminary data demonstrate that unlike other ETS factors, ERG exhibits a highly EC-restricted pattern of expression in cultured primary cells and several adult mouse tissues including the heart, lung, and brain. In response to inflammatory stimuli, such as tumor necrosis factor-&agr;, we observed a marked reduction of ERG expression in ECs. To further define the role of ERG in the regulation of normal EC function, we used RNA interference to knock down ERG. Microarray analysis of RNA derived from ERG small interfering RNA– or tumor necrosis factor-&agr;–treated human umbilical vein (HUV)ECs revealed significant overlap (P<0.01) in the genes that are up- or downregulated. Of particular interest to us was a significant change in expression of interleukin (IL)-8 at both protein and RNA levels. Exposure of ECs to tumor necrosis factor-&agr; is known to be associated with increased neutrophil attachment. We observed that knockdown of ERG in HUVECs is similarly associated with increased neutrophil attachment compared to control small interfering RNA–treated cells. This enhanced adhesion could be blocked with IL-8 neutralizing or IL-8 receptor blocking antibodies. ERG can inhibit the activity of the IL-8 promoter in a dose dependent manner. Direct binding of ERG to the IL-8 promoter in ECs was confirmed by chromatin immunoprecipitation. In summary, our findings support a role for ERG in promoting antiinflammatory effects in ECs through repression of inflammatory genes such as IL-8.

[1]  E. Dejana,et al.  Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. , 2008, Blood.

[2]  P. Oettgen,et al.  Ets-1 Is a Critical Transcriptional Regulator of Reactive Oxygen Species and p47phox Gene Expression in Response to Angiotensin II , 2007, Circulation research.

[3]  P. Oettgen,et al.  A Three-Kilobase Fragment of the Human Robo4 Promoter Directs Cell Type–Specific Expression in Endothelium , 2007, Circulation research.

[4]  V. Kalra,et al.  A Novel Role of Hypoxia-Inducible Factor in Cobalt Chloride- and Hypoxia-Mediated Expression of IL-8 Chemokine in Human Endothelial Cells12 , 2006, The Journal of Immunology.

[5]  B. Göttgens,et al.  Endoglin expression in the endothelium is regulated by Fli-1, Erg, and Elf-1 acting on the promoter and a -8-kb enhancer. , 2006, Blood.

[6]  P. Carmeliet,et al.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality , 2006, The Journal of experimental medicine.

[7]  P. Oettgen,et al.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. , 2006, Blood.

[8]  B. Yard,et al.  Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: role of transcription factors , 2006, Clinical and experimental immunology.

[9]  M. Layne,et al.  Endotoxin-Induced Down-Regulation of Elk-3 Facilitates Heme Oxygenase-1 Induction in Macrophages1 , 2006, The Journal of Immunology.

[10]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[11]  P. Oettgen,et al.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. , 2005, The Journal of clinical investigation.

[12]  Marie Joseph,et al.  Gene Signatures of Progression and Metastasis in Renal Cell Cancer , 2005, Clinical Cancer Research.

[13]  M. Abe,et al.  Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1. , 2004, Biochemical and biophysical research communications.

[14]  Jinjuan Yao,et al.  Myeloid ELF1-like Factor Is a Potent Activator of Interleukin-8 Expression in Hematopoietic Cells* , 2004, Journal of Biological Chemistry.

[15]  M. Layne,et al.  Elk-3 Is a Transcriptional Repressor of Nitric-oxide Synthase 2* , 2003, Journal of Biological Chemistry.

[16]  D. Melton,et al.  "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.

[17]  John Gaspar,et al.  Opposing Functions of the Ets Factors NERF and ELF-1 During Chicken Blood Vessel Development , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Sealfon,et al.  Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. , 2002, Nucleic acids research.

[19]  P. Oettgen,et al.  Cloning and Characterization of the Human Lung Endothelial-Cell-Specific Molecule-1 Promoter , 2002, Journal of Vascular Research.

[20]  S. Brown,et al.  Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. , 2001, Blood.

[21]  S. Reddy,et al.  Increased Transcription of IL-8 in Endothelial Cells Is Differentially Regulated by TNF-&agr; and Oxidized Phospholipids , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[22]  P. Oettgen.  Transcriptional regulation of vascular development. , 2001, Circulation research.

[23]  P. Hewett,et al.  Selective expression of erg isoforms in human endothelial cells. , 2001, The international journal of biochemistry & cell biology.

[24]  T. Libermann,et al.  Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6* , 2001, The Journal of Biological Chemistry.

[25]  T. Libermann,et al.  ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.

[26]  T. Libermann,et al.  ELF-1 Is a Transcriptional Regulator of the Tie2 Gene During Vascular Development , 2001, Circulation research.

[27]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Remy,et al.  The Ets-transcription factor family in embryonic development: lessons from the amphibian and bird , 2000, Oncogene.

[29]  R Favier,et al.  Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. , 2000, Immunity.

[30]  F. Dewitte,et al.  The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis , 2000, Mechanisms of Development.

[31]  T. Libermann,et al.  ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1* , 2000, The Journal of Biological Chemistry.

[32]  T. Libermann,et al.  PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.

[33]  I. Kola,et al.  Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter. , 1999, Journal of cell science.

[34]  P. Remy,et al.  Xl erg: Expression pattern and overexpression during development plead for a role in endothelial cell differentiation , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Thomas N. Sato,et al.  Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. , 1999, Circulation research.

[36]  P. Oettgen,et al.  Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  Yang Wang,et al.  Characterization of the Human Endothelial Nitric-oxide Synthase Promoter* , 1999, The Journal of Biological Chemistry.

[38]  Y. De Launoit,et al.  Requirement of a GT Box (Sp1 Site) and Two Ets Binding Sites for Vascular Endothelial Cadherin Gene Transcription* , 1998, The Journal of Biological Chemistry.

[39]  K. Matsushima,et al.  Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. , 1998, Cytokine & growth factor reviews.

[40]  N. Janel,et al.  Ets transcription factors bind and transactivate the core promoter of the  von Willebrand factor gene , 1997, Oncogene.

[41]  T. Libermann,et al.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family , 1997, Molecular and cellular biology.

[42]  T. Golub,et al.  Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL , 1997, The EMBO journal.

[43]  G. Nash,et al.  Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. , 1997, The American journal of physiology.

[44]  J. Redondo,et al.  Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. , 1996, Blood.

[45]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[46]  T. Libermann,et al.  Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1 , 1996, Molecular and cellular biology.

[47]  T. Libermann,et al.  ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development , 1994, Molecular and cellular biology.

[48]  T. Casale,et al.  TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. , 1994, The American journal of physiology.

[49]  B. Wasylyk,et al.  The Ets family of transcription factors. , 1993, European journal of biochemistry.

[50]  H. Flad,et al.  Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. , 1979, Journal of immunological methods.